Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23835707

PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2013 Aug 10
First author
Paz-Ares LG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Feb 10;32(5):482-3. doi: 10.1200/JCO.2013.53.3448.
    note
    Source null
    related pmid
    24395844
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2014 Feb 10;32(5):483-5. doi: 10.1200/JCO.2013.53.6011.
    note
    Source null
    related pmid
    24395851
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2014 Feb 10;32(5):480-1. doi: 10.1200/JCO.2013.52.9875.
    note
    Source null
    related pmid
    24395856
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2014 Feb 10;32(5):481-2. doi: 10.1200/JCO.2013.53.3893.
    note
    Source null
    related pmid
    24395858
    relationship
    Comment in

Authors and identifiers

  1. name
    Paz-Ares LG
    type
    Author
  2. name
    de Marinis F
    type
    Author
  3. name
    Dediu M
    type
    Author
  4. name
    Thomas M
    type
    Author
  5. name
    Pujol JL
    type
    Author
  6. name
    Bidoli P
    type
    Author
  7. name
    Molinier O
    type
    Author
  8. name
    Sahoo TP
    type
    Author
  9. name
    Laack E
    type
    Author
  10. name
    Reck M
    type
    Author
  11. name
    Corral J
    type
    Author
  12. name
    Melemed S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Paz-Ares LG
    type
    Author
  2. name
    de Marinis F
    type
    Author
  3. name
    Dediu M
    type
    Author
  4. name
    Thomas M
    type
    Author
  5. name
    Pujol JL
    type
    Author
  6. name
    Bidoli P
    type
    Author
  7. name
    Molinier O
    type
    Author
  8. name
    Sahoo TP
    type
    Author
  9. name
    Laack E
    type
    Author
  10. name
    Reck M
    type
    Author
  11. name
    Corral J
    type
    Author
  12. name
    Melemed S
    type
    Author
bibliography ids
  1. nci-bib-fae4379a0cf74268a3c9da88
book metadata
content sha256
5b7e766cc0281bd42b0d8afe48c273587dcf84dd6bbc4c9ec039ff874c355aeb
document type
citation
dois
  1. 10.1200/JCO.2012.47.1102
electronic publication date
display
2013 Jul 8
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:23835707
immutable id
pubmed:23835707@5b7e766cc0281bd42b0d8afe48c273587dcf84dd6bbc4c9ec039ff874c355aeb
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
23
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2895-902
volume
31
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Feb 10;32(5):482-3. doi: 10.1200/JCO.2013.53.3448.
    note
    Source null
    related pmid
    24395844
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2014 Feb 10;32(5):483-5. doi: 10.1200/JCO.2013.53.6011.
    note
    Source null
    related pmid
    24395851
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2014 Feb 10;32(5):480-1. doi: 10.1200/JCO.2013.52.9875.
    note
    Source null
    related pmid
    24395856
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2014 Feb 10;32(5):481-2. doi: 10.1200/JCO.2013.53.3893.
    note
    Source null
    related pmid
    24395858
    relationship
    Comment in
outcomes validated
false
pmid
23835707
provenance
batch id
0a08f044391426feb8ef
provider
NCBI PubMed ESummary
record sha256
bf8d27367ccfc81552bd77455d807e9d114816060b4be75c6efb57b25e63cb26
response sha256
d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
retrieved at
2026-09-09T23:46:57.614689+00:00
publication date
display
2013 Aug 10
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23835707/
title
PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

Preserved source evidence · Not medical advice